Mixed
In patients with type 2 diabetes who have switched from metformin to a second-line antidiabetes medication, a 6-month weight loss is associated with improved glycemic control (lower A1c) and reduced diabetes-specific pharmacy costs.
If you have type 2 diabetes and are considering a medication change after metformin, achieving even modest weight loss over 6 months can significantly improve your blood sugar control and lower your pharmacy bills. Focus on sustainable weight management as part of your treatment plan.
This real-world study suggests that among patients with T2DM, weight loss over a short-term (6-month) period is associated with positive impact on attainment of A1c goals and decreased diabetes-specific pharmacy costs over the subsequent 12 months.
Why this rating
Large observational cohort (n=1,520) with multivariable adjustments, though not a randomized controlled trial.
Source
Association Between Weight Change, Clinical Outcomes, and Health Care Costs in Patients with Type 2 Diabetes
Jayanti Mukherjee et al. · Journal of Managed Care & Specialty Pharmacy · 2016
DOI 10.18553/jmcp.2016.22.5.449
Related findings · Mixed
- Bariatric surgery (VSG and RYGB) is the most effective and sustainable treatment for obesity, producing marked and sustained weight loss that non-surgical interventions cannot match.Strong
- Severely protein-deficient diets (2–3% energy) induce lean body mass loss and metabolic imbalance, whereas adequate protein intake (0.66 g/kg/d minimum) is a prerequisite for maintaining muscle, bone, and physiological function.Strong
- For patients with Class III obesity (BMI >39.9 kg/m2), metabolic bariatric surgery (MBS) is significantly more effective than any currently approved medication, with BilioPancreatic Diversion (BPD) showing the highest estimated weight loss.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →